Targeted Lipidomic Analysis in Human Milk Using LC-MS/MSTriple Quadrupole

Importance of the topic

Human milk contains a highly complex and biologically critical lipidome that supplies energy, essential fatty acids, signaling lipids and molecules that shape infant immune and gastrointestinal development. Reliable, high-throughput and quantitative lipid profiling of human milk is essential for nutritional research, biomarker discovery, evaluation of lactation dynamics, and quality control of donor milk. Analytical challenges include broad concentration ranges, extensive structural isomerism, and strong matrix effects that demand targeted, validated workflows for robust measurement.

Study objectives and overview

The work presents a targeted, high-throughput LC–MS/MS triple quadrupole workflow designed for comprehensive quantitative analysis of the human milk lipidome. Key aims were to achieve broad lipid-class coverage, low limits of quantitation to capture low-abundance signaling lipids, rapid chromatographic throughput compatible with large studies, and rigorous method validation to assess recovery, matrix effects, linearity and precision.

Methodology

Sample preparation and extraction:

• 100 µL human milk aliquots.
• Internal standard mixture spiked prior to extraction to monitor recovery and correct quantitation.
• Protein-lipid extraction using methanol:butanol (1:1 v/v) to a final extract volume of 1 mL, followed by vortexing, sonication, centrifugation and collection of supernatant for LC–MS injection.

Chromatography and mass spectrometry:

• Agilent 1290 Infinity III UHPLC with a ZORBAX RRHD Eclipse Plus C18 column (2.1 × 100 mm, 1.8 µm) operated at ~45 °C, 0.40 mL/min flow, 3 µL injection volume giving a 16-minute LC run.
• Mobile phases based on ammonium formate in acetonitrile/isopropanol/water mixtures optimized for broad lipid elution.
• Agilent 6495D triple quadrupole MS with Agilent Jet Stream ESI operated in both positive and negative ion modes.
• Dynamic multiple reaction monitoring (dMRM) panel targeting >1,200 lipid species across >50 subclasses.

Quantitation and validation approach:

• Isotope-labeled internal standards distributed across retention time and representative of major lipid classes.
• Matrix-matched calibration curves prepared both pre- and post-extraction to assess and correct extraction losses and matrix effects.
• Validation at multiple concentration points (0.01–1 µg/mL and lower for selected analytes) assessing linearity, LOQ, corrected recovery (CR), precision (CV), and matrix effect (ME).

Instrumention used

Key instruments and consumables reported:

• Agilent 1290 Infinity III UHPLC.
• Agilent 6495D triple quadrupole LC/MS system with Agilent Jet Stream ESI.
• Agilent ZORBAX RRHD Eclipse Plus C18 column, 2.1 × 100 mm, 1.8 µm.

Typical MS source and acquisition settings summarized: dynamic MRM acquisition, drying gas 150 °C at 17 L/min, nebulizer 20 psi, sheath gas heater 200 °C at 10 L/min, capillary 3500 V (ESI+) / 3000 V (ESI–), nozzle voltages optimized for polarity modes, and standard iFunnel mode.

Main results and discussion

Coverage and throughput:

• Detection and confirmation of more than 800 distinct lipid species across multiple families (ceramides, cholesteryl esters and derivatives, diacylglycerols, free cholesterol, free fatty acids, glycerophospholipids, triacylglycerols, gangliosides, oxidized lipids, etc.) within a single 16-minute LC run.

Quantitative performance and validation outcomes:

• Matrix-extracted calibration curves achieved coefficients of determination (r2) > 0.99 across validated ranges for all analytes evaluated (typical calibration ranges 0.01–1 µg/mL; select standards validated to 0.002–0.2 µg/mL).
• Corrected recoveries (CR) after use of internal standards and pre/post-extraction calibration were generally within approximately 88–130% across analytes.
• Precision (intra-assay CV) was ≤ 20% at and above LOQ for validated compounds.
• Measured matrix effects varied substantially by analyte (reported ME ranges roughly 10–160%), but use of matrix-matched calibration and isotope-labeled standards compensated for these effects to provide accurate quantitation.
• Limits of quantitation as low as ~0.002 µg/mL were achieved for several internal standards/representative lipids, supporting measurement of low-abundance signaling lipids in milk.

Representative validation examples showed good agreement between pre-spike (extraction) and post-spike quantitation after correction, demonstrating that the workflow adequately corrects for extraction losses and ion suppression/enhancement across lipid classes.

Key benefits and practical applications

The workflow provides several practical advantages:

• High throughput: short LC cycle (16 min) allows processing of large sample cohorts needed for population studies and longitudinal sampling.
• Broad targeted coverage: >1,200 MRM transitions covering >50 subclasses yields deep targeted lipidome characterization suitable for hypothesis-driven studies.
• Robust quantitation: isotope-labeled standards and matrix-matched calibration correct for recovery and matrix effects, delivering reproducible quantitative data with low LOQs.
• Applicability: useful for nutritional and clinical research into milk composition, discovery of lipid biomarkers, assessment of donor milk quality, and studies of maternal-infant lipid transfer and metabolic programming.

Future trends and potential applications

Opportunities to extend and complement this workflow include:

• Integration with high-resolution MS or ion-mobility separations to resolve isomeric lipids (positional and double-bond isomers) that triple quadrupoles cannot distinguish based on MRM alone.
• Expansion of targeted panels and transition libraries to include newly discovered bioactive lipids and oxidized species of interest for infant health research.
• Automation of sample handling, extraction and data processing to further increase throughput and reduce operator variability for large-scale cohort studies.
• Standardization across laboratories through reference materials and inter-laboratory ring trials to enable cross-study comparability.
• Combining targeted lipidomics with other omics layers (metabolomics, proteomics, microbiome) for systems-level studies of lactation biology and infant outcomes.

Conclusions

The targeted LC–MS/MS triple quadrupole workflow described delivers a sensitive, high-throughput and validated approach for quantitative profiling of the complex lipidome of human milk. By combining broad targeted coverage, isotope-labeled internal standards, matrix-matched calibration and short chromatographic runtime, the method supports robust measurement of diverse lipid classes including low-abundance signaling species. The approach is well suited for large-scale studies addressing nutrition, lactation biology and infant health, while future enhancements (HRMS, ion mobility, automation, inter-lab standardization) can further increase resolution and comparability.

References

Key supporting material and cited method reference:

• Huynh K, et al. A Comprehensive, Curated, High-Throughput Method for the Detailed Analysis of the Plasma Lipidome. Agilent Application Note 5994-3747EN, 2021.
• Agilent Technologies, Agilent 1290 Infinity III LC and 6495D Triple Quadrupole System application details and instrument specifications (as reported in the present study).